Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent

Circulation

Volumn 97, Issue 6, 1998, Pages 576-580

  Zhang, Xiaoping ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Bradykinin; Calcium channels; Endothelium derived factors; Nifedipine

Indexed keywords

AMLODIPINE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; COUMARIN DERIVATIVE; DICHLOROISOCOUMARIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ENDOTHELIUM DERIVED RELAXING FACTOR; ICATIBANT; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RAMIPRILAT; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; DOSE RESPONSE; DRUG MECHANISM; HEART FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031912146     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.6.576     Document Type: Article

References (29)

1. Elkayan U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH. A prospective, randomized double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of congestive heart failure. Circulation. 1990;82:1954-1961.
2. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, Adverse Experience Committee. Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation. 1991;83:52-60.
3. Littler WA, Sheridan DJ. Placebo-controlled trial of felodipine in patients with mild to moderate heart failure: UK Study Group. Br Heart J. 1995;71:428-433.
4. Thomas JA, Marks BH. Plasma norepinephrine levels in congestive heart failure. Am J Cardiol. 1968;22:550-558.
5. Packer M, O'Connor CM, Ghali, JK Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL. Effects of amlodipine on morbidity and mortality in severe chronic heart failure: Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 1996;335:1107-1114.
6. Zhang X, Xie Y, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors stimulate nitric oxide production to modulate myocardial oxygen consumption. Circulation. 1997;95:176-182.
7. Kichuk MR, Zhang X, Oz M, Michler R, Kaley G, Nasjletti A, Hintze TH. ACE inhibitors promote nitric oxide production in coronary microvessels from the failing explanted human heart. Am J Cardiol. In press.
8. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
9. Vanhoutte PM, Boulanger CM, Illiano CS, Ngao T, Vidai M, Mombouli JV. Endothelium-dependent effects of converting enzyme inhibitors. J Cardiovasc Pharm. 1993;27:S10-S16.
10. Imura O, Shimamoto K. Role of kallikrein-kinin system in the hypotensive mechanisms of converting-enzyme inhibitors in essential hypertension. J Cardiovasc Pharmacol. 1989;13:S63-S66.
11. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide, physiology, pathophysiology and pharmacology. Pharm Rev. 1991;43:109-142.
12. Dodd MG, Gardiner DG, Carter AJ, Sutton MR, Burges RA. The hemodynamic properties of amlodipine in anesthetized and conscious dogs: comparison with nitrendipine and influence of beu-adrenergjc blockade. Cardiovasc Drugs Ther. 1989;3:545-555.
13. Gerritsen ME, Printz M. Sites of prostaglandin synthesis in the bovine heart and isolated coronary microvessels. Circ Res. 1981;49:1152-1163.
14. Kichuk MR, Seyedi N, Zhang X, Marboe CC, Michler RE, Addonizio LJ, Kaley G, Nasjletti A, Hintze TH. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation. 1996;94:44-51.
15. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide gene expression. Circ Res. 1994;74:349-353.
16. Smith CJ, Sun D, Hoegler C, Roth BS, Zhang X, Zhao G, Xu XB, Kobari Y, Pritchard KJ, Sessa WC. Hintze THE. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 1996;78:58-64.
17. Winbury MM, Howe BB, Hefner MA. Effects of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. J Phamacol Exp Ther. 1969;168:70-95.
18. Maton DT, Braunwald E. The effects of nitroglycerin and amyl nitrate on arterial and venous tone in the human forearm. Circulation. 1965;32:755-766.
19. Vatner SF, Pagani M, Rutherford JD, Millard RW, WT Manders. Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dogs. Am J Physiol. 1978;234:H244-H252.
20. Hintze TH, Vatner SF. Comparison of the effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs. Circ Res. 1983;52(suppl I):I-139-I-146.
21. Murdoch D, Heel RC. Amlodipine: a review of its pharmacologic and pharmacokinetic properties and its therapeutic use in cardiovascular disease. Drugs. 1991;4:478-505.
22. Taylor SH. A review of amlodipine in myocardial ischemia. Postgrad Med J. 1991;67(suppl 5):S48-S51.
23. Magnon M, Gallix P, Cavero I. Intervessel (arteries and veins) and heart/ vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes. J Pharmacol Exp Ther. 1995;275:1157-1166.
24. Bennett MA, Hiller C, Thurston H. Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine. J Hypertens. 1996;14:389-397.
25. o-monomethyl-L-arginine in patients with essential hypertension. J Hypertens. 1994;12:1047-1052.
26. Kishis Y, Watanabe T, Makita T, Sakita S, Watanabe R, Ashikaga T, Numano F. Effect of Nifedipine on cyclic GMP turnover in cultured coronary smooth muscle cells. J Cardiovasc Pharmacal. 1995;26:590-595.
27. Zhang X, Xu X, Forfia PR, Nasjletti A, Hintze TH. Neutral endopeptidase and angiotensin converting enzyme modulate nitric oxide via local kinin formation from canine coronary microvessels. Circulation. 1996;94(Suppl I):I-61. Abstract.
28. Zhang X, Scicli G, Scicli G, Xu X, Nasjletti A, Hintze TH. The role of endothelial kinin formation in the control of nitric oxide production in canine coronary microvessels. Hypertension. 1997;30:1105-1111.
29. Weimer G, Scholkens BA, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endotheliumderived bradykinin. Hypertension. 1991;18:558-563.